Palisade Bio Inc（PALI）價格預測PALIPalisade Bio Inc

Alphio's PALI stock price prediction model matches the current Palisade Bio Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.18 (+1.66%). The 1-week path is $1.22 (+5.15%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Palisade Bio Inc (PALI) is currently not a strong buy due to its low current price of $1.33 and a concerning RSI of 34.158, indicating potential oversold conditions. While the company has received FDA clearance for its Crohn's disease clinical trial, which could drive future growth, it reported a significant net loss of $10.6 million in Q2 2026, raising concerns about its financial health. The stock has also seen a year-to-date decline of 46.80%, reflecting market skepticism. However, the analyst price targets suggest a potential upside of 350% to 500%, which could be attractive for long-term investors willing to accept the risks involved.

Palisade Bio Inc (PALI) last closed at $1.16, losing -2.52%. These facts feed the 1-day and 1-week PALI price prediction above.